Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
NCT ID: NCT04538469
Last Updated: 2020-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2020-09-30
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
COVID-19 changed visiting for all patients in hospitals across Scotland. It is not known what effect these restrictions will have on patients' recovery, nor do we understand the impact it may have on their relatives or staff caring for them. This study will look at the implications of the visiting restrictions as a consequence of the COVID-19 pandemic upon patients without COVID-19 who are in the cardiothoracic ICU. It will also explore the impact of these restrictions on them, their relatives and staff.
This study will be carried out within a single specialised intensive care unit in Scotland using mixed methods.
The first arm of this study will use retrospective data that is routinely collected in normal clinical practice. The investigators will compare patient outcomes prior to COVID-19 with outcomes following the implementation of COVID-19 visiting restrictions. The aim is to establish if the restrictions on visiting has an impact on the duration of delirium. Delirium is an acute mental confusion and is associated with longer hospital stays and worse outcomes in this patient group.
The second arm of this study involves semi-structured interviews with patients, relatives and staff that will allow deeper exploration of the issues around current visiting policy. The interviews will last approximately 1 hour and will address these issues. They will then be transcribed word for word and analysed using grounded theory, meaning the theories will develop from the data as it is analysed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Delirium After Cardiac Surgery in Intensive Care Units
NCT06355570
WHO Covid 19 - Neurological Abnormalities in SARS-CoV-2 ICU Patients
NCT04643548
Mobilisation in the EveNing to TreAt Delirium
NCT05401461
Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic
NCT04389463
Nurses' Knowledge, Barriers and Practices in the Assessment of Delirium in the Intensive Care Unit
NCT05384964
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators hypothesise that the restriction of visiting has a negative impact on recovery of patients, families of patients and staff caring for patients without COVID-19 in the cardiothoracic ICU.
In order to answer this hypothesis, the wider implications of COVID-19 will be explored, not only with patients, but also relatives and staff involved in the care of these patients.
The research questions this study aims to answer are:
1. Is there a negative impact on the clinical outcomes due to the COVID-19 visitation restrictions?
2. Is there an increase in the incidence and duration of delirium in patients who do not receive visitors?
3. What experiences do patients recall during their ICU admission through the COVID-19 pandemic visitation restrictions?
4. What experiences do relatives recall from their loved-ones during an ICU admission during the COVID-19 pandemic visitation restrictions?
5. What impact, if any, do the changes to visiting have on staff?
In order to answer these research questions the investigators will carry out a single centre mixed method observational study. This study will consist of two arms.
The first arm of this study will utilise retrospective data that is routinely collected in normal clinical practice in this single centre. This will be used to compare to patient outcomes prior to COVID-19 with outcomes following the implementation of COVID-19 visiting restrictions.
The second arm of this study involves semi-structured interviews with patients, relatives and staff that allow deeper exploration of the issues around current visiting policy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Admitted prior to COVID visitation restrictions introduced
No interventions assigned to this group
Group 2
Admitted following the introductions of visitation restrictions due to COVID 19 pandemic
COVID visitation restrictions
Visitation to patients in hospitals in Scotland was ceased due to the COVID 19 pandemic. Slow reintroduction of visitors has been introduced, however not to the pre COVID 19 levels. This study will examine the effects of these restrictions on patients in the cardiothoracic critical care unit that do not suffer from COVID 19.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID visitation restrictions
Visitation to patients in hospitals in Scotland was ceased due to the COVID 19 pandemic. Slow reintroduction of visitors has been introduced, however not to the pre COVID 19 levels. This study will examine the effects of these restrictions on patients in the cardiothoracic critical care unit that do not suffer from COVID 19.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Patients who have been admitted:
* Following cardiac or thoracic surgery or,
* For treatment of advanced heart failure
For Patients:
* Length of stay within critical care \> 4 days
* Age \> 18 years
* Reason for admission
* Post-operative patients following cardiac or thoracic surgery or,
* Following admission for advanced heart failure therapies
* Provision of informed consent
For relatives:
* Age \> 18 years
* Relative of a patient that has been in critical care \> 4 days
* Relative of a patient who has been admitted:
* Following cardiac or thoracic surgery or,
* Treatment of advanced heart failure
* Relative of a patient admitted for \> 4days
For Staff:
* Age \> 18
* Clinical responsibility within the critical care department
Exclusion:
For patients:
* Prisoners
* Age \< 18yrs
* No family or social support
* Non-English speaker
* Pre-admission evidence of cognitive impairment
* Pre-admission diagnosis of learning disability
* Imminent death
* Brain injury
* Lacks capacity (using Montreal Cognitive Assessment tool (MoCA))
* Patients admitted after out of hospital cardiac arrest
* Patients admitted to the ICU following ENT procedures
* Patients admitted to the ICU following orthopaedics procedure
* Patients admitted to the ICU following general surgical procedures
* Patients admitted with COVID-19 pneumonia
For relatives:
* Prisoner
* Age \< 18yrs
* Non-English speaker
* Relative of a patient who is close to death
* Relative of a patient admitted after out of hospital cardiac arrest
* Relative of a patient admitted for ENT procedure
* Relative of a patient admitted for orthopaedic procedure
* Relative of a patient admitted following general surgical procedure
For Staff:
• Age \< 18yrs
Exclusion Criteria
* Diagnosed learning disability
* Pre-admission evidence of cognitive impairment
* Patients admitted to the ICU following ear nose and throat (ENT) procedures
* Patients admitted to the ICU following orthopaedics procedure
* Patients admitted to the ICU following general surgical procedures
* Patients admitted following out of hospital cardiac arrest
* Patients admitted for COVID-19 pneumonia
Arm 2
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Golden Jubilee National Hospital
OTHER_GOV
University of Glasgow
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Ben Shelley
Chief Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ben Shelley
Role: STUDY_CHAIR
National Waiting Times Centre Board
Leah Hughes
Role: PRINCIPAL_INVESTIGATOR
National Waiting Times Centre Board
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20/ANAES/02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.